Palvella Therapeutics Inc.
XNAS: PVLA
Palvella Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...
Read More
53.51
0.80
(1.52%)
50,519
XNAS Volume
XNAS 03 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Palvella Therapeutics Inc. is on 08 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Palvella Therapeutics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..